Digital PCR market Market by Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Size, Opportunities, Segmentation and Forecast 2015 – 2021

July 2015 | 140 pages | ID: D22B9A8B951EN
Occams Business Research & Consulting

Abstracts

The polymerase chain reaction (PCR) technologies market reached over $6.5 billion at the end of 2013. PCR enables quantification and detection of target DNA. PCR is a valuable tool in diagnosis, clinical trials and drug discovery. PCR application in critical research areas such as gene expression analysis, genotyping, viral quantification, HIV DNA detection and quantification etc. have provided valuable data to the field of medical science. Quantitative real-time PCR (qPCR) is being used largely by bio-pharma and academic labs. However, digital PCR (dPCR) are gaining focus currently. FDA approvals for clinical diagnosis and drugs depend on the clarity and consistency of results. For example qPCR based tests may have issues with respect to amplification efficiency that could vary with PCR primers and type of patient. Therefore, in such cases dPCR produces results that are more consistent. dPCR provide higher level of precision and greater sensitivity. This can directly affect the time span of FDA approvals.

1. Roche
2. Bio-Rad Labs
3. Life Technologies (Applied Biosystems and Invitrogen)
4. Qiagen
5. Promega
6. Agilent Technologies
7. Thermo Fisher Scientific
8. Sigma-Aldrich
9. Biorigami
10. Raindance technology
11. MDX health
12. GE
13. BIOKE
14. Integrated DNA technologies
15. Sony DADC
16. Ambry genetics
17. Pacific bio sciences
18. Bioline

This Occams Research Report covers

1. Historical data
2. Revenue forecasts, growth rates and CAGR upto 2021
3. Industry Analysis
4. Competitive Analysis
5. Key geographic growth data

Contents

1. EXCEUTIVE SUMMARY

2. KEY COMPONENTS OF PCR – INSTRUMENTATION, SERVICES, REAGENTS AND MEDIA ETC: A SNAP SHOT

3. QPCR VERUSUS

4. REGULATIONS

5. CONVENTIONAL PCR, QPCR VERSUS DPCR

6. KEY APPLICATION AREAS OF PCR TECHNOLOGY

7. KEY MOTIVATORS FOR ADOPTION OF DPCR

8. KEY RESTRAINTS FOR ADOPTION OF DPCR

9. OPPORTUNITY ANALYSIS

10. VALUE CHAIN ANALYSIS ACROSS STAKEHOLDERS

(Instrument Manufacturers, Reagent Providers, Services etc)

11. KEY BUYING CRITERIA

12. STRATEGIC RECOMMENDATIONS

13. COMPETITIVE INTELLIGENCE

13.1. Key Companies
13.2. Market Share

14. DPCR MARKET BY COMPONENTS ($MILLION), 2014 TO 2021

14.1. dPCR Instrument Market
14.2. Reagents and Consumable
14.3. dPCR Software and Analytics
14.4. Others

15. DPCR MARKET BY APPLICATIONS ($MILLION), 2014 TO 2021

15.1. Disease Diagnosis
15.2. Clinical Trials
15.3. Drug Development
15.4. Forensic Applications
15.5. Research Applications
15.6. Others

16. GEOGRAPHIC ANALYSIS

16.1. North America ($Million), 2014 to 2021
  16.1.1. U.S.
  16.1.2. Canada
16.2. Europe ($Million), 2014 to 2021
  16.2.1. Eastern
  16.2.2. Western
  16.2.3. Central
  16.2.4. Southern
16.3. Asia ($Million), 2014 to 2021
  16.3.1. China
  16.3.2. India
  16.3.3. Korea
  16.3.4. Japan
  16.3.5. Australia
  16.3.6. Other Pacific
16.4. Row ($Million), 2014 to 2021

17. CORPORATE PROFILING

17.1. Company Overview
17.2. Business Units and Services
17.3. Highlights
  17.3.1. Strategic input
  17.3.2. Strategic input
  17.3.3. Strategic input
17.4. Financial Review
17.5. SCOT Analysis
17.6. List of Companies
  1. Roche
  2. Bio-Rad Labs
  3. Life Technologies (Applied Biosystems and Invitrogen)
  4. Qiagen
  5. Promega
  6. Agilent Technologies
  7. Thermo Fisher Scientific
  8. Sigma-Aldrich
  9. Biorigami
  10. Raindance technology
  11. MDX health
  12. GE
  13. BIOKE
  14. Integrated DNA technologies
  15. Sony DADC
  16. Ambry genetics
  17. Pacific bio sciences
  18. Bioline

List Of Tables

LIST OF TABLES

1. Global Digital PCR market by region, 2013-2021 (in $million)
2. Global Digital PCR market by components, in $million (2013-2021)
3. Global Digital PCR market by instruments, in $million (2013-2021)
4. Global Digital PCR market by reagents and consumables, 2013-2021 (in $million)
5. Global Digital PCR market software and analytics market, 2013-2021 (in $million)
6. Global Digital PCR market for other components, 2013-2021 (in $million)
7. Global Digital PCR market applications, 2013-2021 (in $million)
8. Global Clinical trials factsheet, 2013
9. Global Digital PCR market by Region in $million (2013-2021)
10. North America Digital PCR market, 2013-2021 (in $million)
11. Asia-Pacific Digital PCR market, 2013-2021 (in $million)
12. Europe Digital PCR market, 2013-2021 (in $million)
13. Rest of the world Digital PCR market, 2013-2021 (in $million)

List Of Figures

LIST OF FIGURES

1. Value Chain Analysis
2. Digital PCR market share (%) in 2013
3. Key buying criteria
4. Figure 6: US in Digital PCR market, 2013-2021 (in $million
5. Figure 7: Canada Digital PCR market, 2013-2021 (in $million)
6. Figure 8: China Digital PCR market, 2013-2021 (in $million)
7. Figure 9: India Digital PCR market, 2013-2021 ($million)
8. Figure 10: Japan Digital PCR market, 2013-2021 ($million)
9. Figure 11: Australia Digital PCR market, 2013-2021 (in $million)
10. Figure 12: RoAPAC Digital PCR market, 2013-2021 (in $million
11. Figure 13: France Digital PCR market, 2013-2021 (in $million)
12. Figure 14: Germany Digital PCR market, 2013-2021 (in $million)
13. Figure 15: UK Digital PCR market, 2013-2021 (in $million)